Smaragda Papachristidou

Mrs. Smaragda Papachristidou


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
GPGeorge Pantalos
George Pantalos
SPSmaragda Papachristidou
Smaragda Papachristidou
EMEleftheria Mavrigiannaki
Eleftheria Mavrigiannaki
NZNikolaos Zavras
Nikolaos Zavras
ΓΒΓεώργιος Βάος
Γεώργιος Βάος
Global pandemics cause health system disruptions. The inadvertent disruption in surgical emergency care during the Coronavirus Disease 2019 (COVID-19) pandemic has been the topic of several published studies. Our aim was to summarize the reasons that led to the delayed diagnosis of pediatric appendicitis during the COVID-19 era. This systematic literature search evaluated studies containing pediatric appendicitis patient data regarding outcomes, times to hospital admission or times from symptom onset to emergency department visit. Studies elucidating reasons for delays in the management of pediatric appendicitis were also reviewed. Ultimately, 42 studies were included. Several reasons for delayed diagnosis are analyzed such as changes to public health measures, fear of exposure to COVID-19, increased use of telemedicine, COVID-19 infection with concurrent acute appendicitis, recurrence of appendicitis after non-operative management and increased time to intraoperative diagnosis. Time to hospital admission in conjunction with patient outcomes was extracted and analyzed as an indicative measure of delayed management. Delayed diagnosis of acute appendicitis has been documented in many studies with various effects on outcomes. Suspicion of pediatric acute appendicitis must always lead to prompt medical examination, regardless of pandemic status. Telemedicine can be valuable if properly applied. Data from this era can guide future health system policies.

22 July 2021 in Journal of Pediatric Hematology/Oncology
Verified
Journal Article
Closed access
ASAngeliki-Eleni Md Sfetsiori
Angeliki-Eleni Md Sfetsiori
DDDimitrios MD Doganis
Dimitrios MD Doganis
Anastassios DoudoulakakisAnastassios Doudoulakakis
Anastassios Doudoulakakis
NSNikolaos Spyridis
Nikolaos Spyridis
APApostolos Pourtsidis
Apostolos Pourtsidis
MTMaria Tsolia
Maria Tsolia
Background: Identifying potential predictive factors for the type of bacteremia (Gram-negative vs. Gram-positive) in children with cancer would be crucial for the timely selection of the appropriate empiric antibiotic treatment. Materials and Methods: Demographic, clinical, and laboratory characteristics of children with cancer and a bacterial bloodstream infection (BSI) (February 1, 2011 to February 28, 2018) in a tertiary pediatric oncology department were retrospectively examined and were correlated with the type of isolated bacteria. Results: Among 224 monomicrobial bacterial BSI episodes, Gram-negative and Gram-positive bacteria were isolated in 110 and 114 episodes, respectively. Gram-negative bacteria were isolated significantly more frequently in girls (Gram-negative/Gram-positive ratio 1.7:1) versus boys (Gram-negative/Gram-positive ratio 0.72:1), P=0.002, in patients with previous BSI episodes (1.4:1) versus those without (0.8:1), P=0.042, and in children with hematologic malignancy (1.3:1) versus those who suffered from solid tumors (0.52:1), P=0.003. Gram-negative BSI episodes were more frequently correlated with a lower count of leukocytes, P=0.009, neutrophils, P=0.009 and platelets, P=0.002, but with significantly higher C-reactive protein (CRP) levels, P=0.049. Female sex, hematologic malignancy, and higher CRP levels remained independent risk factors for Gram-negative BSI in the multivariate analysis. Among neutropenic patients, boys with solid tumors and a recent central venous catheter placement appear to be at increased risk for Gram-positive BSI in the multivariate analysis. Conclusions: Although Gram-negative and Gram-positive BSIs are close to balance in children with cancer, Gram-negative bacteria are more likely to be isolated in girls, children with hematologic malignancies and those with higher CRP level at admission. In contrast, neutropenic boys with solid tumors and a recently placed central venous catheter may be at increased risk for Gram-positive BSI indicating probably the need for initially adding antibiotics targeting Gram-positive bacteria.

6 October 2023 in Vaccine
Verified
Journal Article
Closed access
SPSmaragda Papachristidou
Smaragda Papachristidou
VLVasiliki Lapea
Vasiliki Lapea
MCMartha Charisi
Martha Charisi
EKEleni Kourkouni
Eleni Kourkouni
DKDimitra Kousi
Dimitra Kousi
MTMaria Tsolia
Maria Tsolia

13 September 2025 in EJC Paediatric Oncology
Verified
Journal Article
Open access
SPSmaragda Papachristidou
Smaragda Papachristidou
DDDimitrios Doganis
Dimitrios Doganis
GKGeorgia Kourlaba
Georgia Kourlaba
GPGeorge Pantalos
George Pantalos
SPSophia Pasparaki
Sophia Pasparaki
MTMaria Tsolia
Maria Tsolia

1 December 2020 in Forum of Clinical Oncology
Verified
Journal Article
Open access
APApostolos Pourtsidis
Apostolos Pourtsidis
SPSmaragda Papachristidou
Smaragda Papachristidou
OAOrthodoxos Achilleos
Orthodoxos Achilleos
DMDarius F. Mirza
Darius F. Mirza
MSMarina Servitzoglou
Marina Servitzoglou
MBMargarita Baka
Margarita Baka
Introduction: Pancreatic tumors are reported rarely in childhood and represent an extremely rare entity in Pediatric Oncology. One of the least common types of pediatric pancreatic tumor is acinar cell carcinoma (ACC). We aim to present a rare case of ACC and the difficulties we faced during diagnosis and treatment. Patient and Methods: An 8-year old girl presented with jaundice. Workup revealed a tumor originating from the head of the pancreas with multiple metastatic lesions in her liver. Evaluation of tumor markers revealed elevated levels of AFP. Pathology report was indicative of acinar cell carcinoma of the pancreas. Results: After consulting the EXPeRT group (European Cooperative Study Group for Pediatric Rare Tumors), chemotherapy was initiated. Partial response was observed after the first 4 courses with decrease of AFP levels. While planning her surgery, AFP elevated and a second-line course of chemotherapy was administered. Our patient underwent Whipple’s Duodenopancreatectomy with partial metastasectomy. Although the postoperative period was uneventful, AFP continued to rise even after postoperative chemotherapy was administered. There were signs of metastatic disease progression. Our patient received a third-line regimen with no improvement. She received local radiotherapy and a next-line chemotherapy course. Local relapse and metastatic disease progression placed our patient in palliative care. She passed away nine months after the initial diagnosis. Conclusions: Acinar cell carcinoma of the pancreas is a rare type of pediatric cancer with very challenging diagnosis and treatment. Cooperation at the European level and multicenter management of those rare cases is vital for the optimum outcome.

2 January 2026 in Medicina
Verified
Journal Article
Open access
PDF file
SPSmaragda Papachristidou
Smaragda Papachristidou
DDDimitra Dimopoulou
Dimitra Dimopoulou
GPGeorge Pantalos
George Pantalos
DDDimitrios Doganis
Dimitrios Doganis
SPSophia Pasparaki
Sophia Pasparaki
MTMaria Tsolia
Maria Tsolia
Background and Objectives: Febrile neutropenia (FN) is a potentially life-threatening complication in children undergoing cancer treatment. Immediate initiation of empirical antibiotic treatment (EAT) has improved the prognosis and outcomes of FN. Although the ideal timing for initiating EAT is clear, the optimal timing for EAT discontinuation remains debatable. Early hospital discharge (EHD) with continuation of oral antibiotics has also been proposed as an alternative strategy. This narrative review aims to present a comprehensive overview of the evidence on early discontinuation of EAT or EHD in children with FN and cancer. Materials and Methods: A comprehensive literature search was performed to identify relevant studies assessing early EAT discontinuation or EHD in children with cancer and FN. Extracted data included the safety outcomes, the benefits for the patients and the cost for healthcare systems. Results: Thirty-one studies were included; twenty-one investigated the early discontinuation of EAT and ten studies evaluated EHD. Most studies reported early discontinuation of EAT or EHD as a safe FN treatment approach with potential benefits for the patients, especially when applied to selected low-risk FN cases. Reported benefits included shorter hospitalization duration and reduced antibiotic use, with additional economic advantages in several studies. Conclusions: Early discontinuation of EAT appears to be a safe and beneficial management approach for children with FN and cancer by reducing the length of hospital stay and the duration of antibiotic use. EHD with oral therapy continuation also appears to be safe but less beneficial than early discontinuation of EAT. High-quality evidence and standardized criteria are needed to support broader implementation of these strategies in routine clinical practice.